RSS-Feed abonnieren
DOI: 10.1055/s-2008-1078248
cis-Dihydroxylation of Alkenes by a Non-Heme Iron Enzyme Mimic
Publikationsverlauf
Publikationsdatum:
05. August 2008 (online)

Abstract
Using the non-heme iron oxidase active site as a template, a peptidomimetic ligand has been designed, synthesized, and used to effect the dihydroxylation of alkene substrates. Fenton-type radical pathways are also observed.
Key words
alkenes - bioorganic chemistry - dihydroxylations - iron - oxygenations
- 1
Ortiz de Montellano PR. Cytochrome P-450 Structure, Mechanism and Biochemistry Plenum; New York: 1995. -
2a
Que L.Ho RYN. Chem. Rev. 1996, 96: 2607 -
2b
Kappock TJ.Caradonna JP. Chem. Rev. 1996, 96: 2659 - 3
Wallar BJ.Lipscomb JD. Chem. Rev. 1996, 96: 2625 - 4
Karlsson A.Parales JV.Parales RE.Gibson DT.Eklund H.Ramaswamy S. Science 2003, 299: 1039 - 5
Burzlaff NI.Rutledge PJ.Clifton IJ.Hensgens CMH.Pickford M.Adlington RM.Roach PL.Baldwin JE. Nature (London) 1999, 401: 721 - 6
Barton DHR. Tetrahedron 1998, 54: 5805 - 7
Chen K.Que L. Angew. Chem. Int. Ed. 1999, 38: 2227 -
8a
Bugg TDH. Tetrahedron 2003, 59: 7075 -
8b
Costas M.Mehn MP.Jensen MP.Que L. Chem. Rev. 2004, 104: 939 -
8c
Shan XP.Que L. J. Inorg. Biochem. 2006, 100: 421 - 9
Oldenburg PD.Que L. Catal. Today 2006, 117: 15 -
10a
Rohde J.-U.In J.-H.Lim MH.Brennessel WW.Bukowski MR.Stubna A.Munck E.Nam W.Que L. Science 2003, 299: 1037 -
10b
Oldenburg PD.Shteinman AA.Que L. J. Am. Chem. Soc. 2005, 127: 15672 -
10c
Oldenburg PD.Ke CY.Tipton AA.Shteinman AA.Que L. Angew. Chem. Int. Ed. 2006, 45: 7975 - 11
Chen MS.White MC. Science 2007, 318: 783 - 12
Krall JA.Rutledge PJ.Baldwin JE. Tetrahedron 2005, 61: 137 -
13a
Hegg EL.Que L. Eur. J. Biochem. 1997, 250: 625 -
14a
Seebach D.Naef R. Helv. Chim. Acta 1981, 64: 2704 -
14b
Seebach D.Naef R.Calderari G. Tetrahedron 1984, 40: 1313 - 17
Walling C. Acc. Chem. Res. 1975, 8: 125
References and Notes
Conversion of 5 into 9 was achieved as detailed in ref. 12. Then
a solution of ethylaniline 4 (0.19 mL,
1.49 mmol) in THF (10 mL) was cooled to 0 ˚C and n-BuLi (1.5 M, 1.19 mL) added via syringe.
The yellow solution was stirred at 0 ˚C for 20
min, then DMPU (0.22 mL, 1.78 mmol) was added and the solution stirred
for a further 20 min. The mixture was cooled to -40 ˚C
and added via cannula to a solution of 9 (500
mg, 1.24 mmol) in THF (10 mL) also at -40 ˚C. The
reaction was stirred at -40 ˚C for 5
h, then left to warm to r.t. overnight, The mixture was poured onto
half-saturated NH4Cl solution (4 mL), and the aqueous
phase was extracted with Et2O (3 × 8 mL). The
organic extracts were combined, dried, and concentrated in vacuo.
The crude product was purified by column chromatography (SiO2,
10:1 cyclohexane-EtOAc) to give 10 as
a yellow oil (470 mg, 85%).
Compound 10 (150 mg, 0.34 mmol) was dissolved in
THF (0.30 mL); aq LiOH (1 M, 0.44 mL) was added. The mixture was
heated at reflux for 17 h, then cooled to r.t., adjusted to pH 7
with 1 M HCl and extracted with CH2Cl2 (3 × 1
mL). The organic phases were combined, dried, and evaporated to a
yellow oil which solidified under vacuum. Trituration with Et2O
(3 × 2 mL) gave 3 as an off-white
solid (120 mg, 95%).
Characterization
Data for (S)-3-{6-[(Ethyl-phenyl-amino)-methyl]-pyridin-2-yl}-2-hydroxy-2-phenyl-propionic
Acid 3
R
f
= 0.2 (CH2Cl2-MeOH,
10:1); [α]D
²0 -92.6
(CHCl3, c 0.38); mp 110-112 ˚C.
IR (KBr): νmax = 3355 (w, OH str), 1612
(s, C=O str), 1505 (m, C=C str), 1575 (m, C=C
str), 807, 745 cm-¹. ¹H
NMR (300 MHz, CD3OD): δ = 1.24 (3 H, t, J = 7.0 Hz,
NCH2CH
3), 3.56
(2 H, q, J = 7.0
Hz, NCH
2CH3), 3.64
(1 H, d, J = 14.5
Hz, 1 of CH
2CC6H5),
3.53 (1 H, d, J = 14.5
Hz, 1 of CH
2CC6H5),
4.57 (2 H, s, CH2N), 6.65 (3 H, m, 3 NC6H5),
7.05 (1 H, d, J = 7.5
Hz, py-Hδ), 7.12-7.29 (6 H, m, 3 of
CC6H5, 2 of NC6H5, py-Hβ),
7.54 (1 H, t, J = 7.0
Hz, py-Hγ), 7.76 (2 H, m, 2 of CC6H5). ¹³C
NMR (75 MHz, CDCl3): δ = 11.26 (NCH2
CH3), 44.82 (CH2CC6H5),
48.85 (NCH2CH3),
55.11 (CH2N), 79.64 (CC6H5),
111.09 (CH of C6H5), 115.25 (py-Cβ),
117.43 (py-Cδ), 121.94, 125.17, 125.35, 126.35,
128.15 (CH of C6H5), 136.61 (py-Cγ),
141.97 (Cipso of CC6H5), 146.55
(Cipso of NC6H5), 157.02 (py-Cα),
158.21 (py-Cε), 176.53 (C=O). MS (ES+): m/z (%) = 377
(100) [MH]+, 359 (45) [MH -H2O]+. HRMS
(ES+): m/z calcd for C23H24N2O3:
377.1865; found: 377.1860 (100%) [MH]+.
Turnover Procedure
Methanol
was distilled over CaH2 and degassed in three freeze-thaw
cycles before use. All substrates were distilled over CaH2 and
passed through activated alumina before use to remove any peroxides.
All reactions were carried out under an atmosphere of argon. Ligand 3 (50 mg, 0.13 mmol) was dissolved in anhyd
CH2Cl2 (0.75 mL) and treated with NaH (12
mg, 0.53 mmol). After stirring for 45 min at r.t. the solvent was
removed in vacuo to give the sodium salt of 3 as a
white powder. To a suspension of this salt (4.0 mg, 10 µmol)
in MeOH (0.20 mL) was added Fe(OAc)2 (1.7 mg, 10 µmol)
in MeOH giving a yellow solution which was stirred at r.t. for 45
min. The solution was diluted with MeOH (15 mL), and the substrate
alkene (10 mmol) was added. Hydrogen peroxide (100 µmol,
30% aq) diluted in MeOH (1 mL) was added to the
stirring solution over 4 h, and the solution was stirred at r.t.
for a further 12 h. The reaction was reduced in vacuo, diluted with
EtOAc and filtered through SiO2. n-Decane
was added as an internal standard. Products 12-16 were analyzed by gas chromatography
and GC-MS and identified unambiguously by comparison with authentic samples.
Gas
chromatography was carried out on a Hewlett-Packard 5890 Series
II gas chromatograph fitted with an HP-1ms column (30 m × 0.25
mm ID, 0.25 µm;S/N US2469051H), and (to distinguish cis- and trans-diols)
a Hewlett-Packard 5890A gas chromatograph fitted with a BP-20 column (25 m × 0.22
mm ID, 0.25 µm) and ChemStation software. Both chromatographs
were equipped with split/splitless capillary inlets and
flame-ionisation detectors (FID).